Please login to the form below

Not currently logged in


This page shows the latest mRNA-4157 news and features for those working in and with pharma, biotech and healthcare.

Moderna posts encouraging early data for personalised cancer vaccine

Moderna posts encouraging early data for personalised cancer vaccine

The vaccine, mRNA-4157, is being evaluated in combination with Merck &Co’s PD-1 inhibitor Keytruda (pembrolizumab) in different cancer types. ... According to Moderna, the data showed that mRNA-4157 is well tolerated, with adverse events being

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...